Newsletter — 2026-10
University of Michigan Opens $10M Histotripsy Center to Expand Ultrasound Tumor Ablation
Sent 2026-10-01
This issue covers everything relevant published between 2026-09-01 and 2026-10-01, automatically gathered from PubMed and web search, alongside newly evaluated products on the site.
Image-guided therapies
Diagnostic yield and predictors of complications in CT-guided percutaneous lung biopsy: an analysis based on ATS/ACCP criteria.
La Radiologia medica · 2026 Sep 30
A real-world cohort study of CT-guided percutaneous lung biopsy evaluated diagnostic yield and complication predictors using ATS/ACCP criteria, reinforcing CT-PLB's role as a cornerstone diagnostic technique for pulmonary nodules even as alternatives like robotic bronchoscopy emerge.
Comparison of the difference between the actual ablation zone in lung tumors after computed tomography-guided percutaneous microwave ablation and the predicted value in the planning system: A retrospective study.
Journal of cancer research and therapeutics · 2026 Sep 1
In a retrospective analysis of 134 lung tumors treated with CT-guided microwave ablation, predicted ablation zone diameters and spherical index from the planning system closely matched actual post-ablation zones at 24 hours but were significantly larger than actual measurements at later follow-up, informing more accurate procedural planning.
CT-guided core needle biopsy in ultrasound-inaccessible suprahyoid deep neck spaces.
European radiology · 2026 Sep 28
A retrospective review of 122 CT-guided core needle biopsies in 118 patients with ultrasound-inaccessible suprahyoid deep neck lesions assessed diagnostic yield, procedural safety, and concordance with surgical pathology, demonstrating CT guidance as a viable option for these technically challenging sites.
Pain management in osteoarthritis of the hip using percutaneous obturator nerve neuromodulation with pulsed radiofrequency ablation under CT guidance.
Hip international : the journal of clinical and experimental research on hip pathology and therapy · 2026 Sep 27
In 33 hips from 30 patients with refractory hip osteoarthritis, CT-guided pulsed radiofrequency ablation of the obturator nerve was evaluated for pain relief using VAS scores at multiple follow-up timepoints up to 12 months, offering a minimally invasive option for conservative-treatment-refractory cases.
New on the webpage
Atlas Laser Robot Arm
https://microtherapy.world/products/atlas-laser-robot-arm-a04b3c4a
Initial score: 35/60 — GOOD
EmeryGlide Guidewire — trackr. Platform (Nano4Imaging)
https://microtherapy.world/products/emeryglide-guidewire-nano4imaging
Initial score: 43/60 — GOOD
New clinical studies
Pre-Spondylectomy Radiofrequency Ablation for Spinal Chordoma: An Illustrative Case and Systematic Review of Clinical Applications and Outcomes.
Current oncology (Toronto, Ont.) · 2026 Sep 20
A systematic review of 13 studies encompassing 33 patients and 34 thermal ablation procedures (including radiofrequency ablation, cryoablation, and laser interstitial thermal therapy) evaluates the use of ablation as a pre-spondylectomy adjunct or alternative for spinal/sacral chordoma, illustrated by a case example.
Saline tract sealing to prevent pneumothorax and chest tube placement after computed tomography (CT)-guided lung biopsy: a systematic review and meta-analysis.
Clinical radiology · 2026 Sep
This systematic review and meta-analysis assesses saline and other tract-sealing techniques (autologous blood, fibrin glue, collagen plugs) to reduce pneumothorax—which occurs in roughly 25% of CT-guided lung biopsies and necessitates chest tube placement in 5-6%—offering guidance on cost-effective complication prevention.
Tract Embolization versus No Embolization after CT-Guided Lung Biopsy: A Systematic Review and Meta-Analysis.
Journal of vascular and interventional radiology : JVIR · 2026 Sep
A meta-analysis pooling studies through March 2025 compares tract embolization versus no embolization after CT-guided percutaneous lung biopsy, calculating risk ratios, absolute risk reduction, and number needed to treat, with subgroup analyses by embolic agent and chest tube placement criteria to clarify whether embolization meaningfully reduces pneumothorax risk.
Robotic-assisted surgeries
Robotic Needle Insertion for CT-guided Percutaneous Biopsy of Thoracoabdominal Lesions: A Prospective Multicenter Randomized Trial.
Radiology. Imaging cancer · 2026 Sep
A prospective multicenter randomized trial (n=165) compared a novel CT-guided robotic needle insertion system to freehand technique for thoracoabdominal biopsies, evaluating technical success, targeting error, and number of CT scans/needle adjustments.
Robotic-Assisted Computed Tomography-Guided Percutaneous Bone Procedures: A Prospective Multicenter Pilot Study.
Cardiovascular and interventional radiology · 2026 Sep
A prospective multicenter pilot study evaluated the feasibility, safety, and targeting accuracy of robotic-assisted CT-guided percutaneous bone consolidation and biopsy procedures.
Robot-assisted CT-guided interventions: Where are we now and where are we going?
European radiology · 2026 Sep 5
This narrative review maps current evidence on robot-assisted CT-guided interventions using the IDEAL framework, noting preclinical studies consistently show improved targeting accuracy, while clinical evidence on measurable patient benefit is still evolving.
MRI-guided endovascular robotics: A roadmap to MRI-native systems.
APL bioengineering · 2026 Sep
A perspective piece outlines a roadmap toward MRI-native endovascular robotic systems, arguing that progress requires MRI-robot co-design rather than compatibility-driven adaptation of existing catheter platforms.
Upcoming conferences
RSNA 2026 (112th Scientific Assembly and Annual Meeting)
November 29 – December 3, 2026 · McCormick Place, Chicago, IL, USA — World's largest annual radiology forum; includes AI Showcase and extensive interventional/image-guided therapy programming.
https://www.rsna.org/annual-meeting/exhibitors-and-sponsors/planning-your-exhibit
Symposium on Clinical Interventional Oncology (CIO) 2026
November 14–15, 2026 · The Westin Fort Lauderdale Beach Resort, Fort Lauderdale, FL, USA — Practical, case-based interventional oncology meeting with hands-on workshops for IRs and multidisciplinary cancer teams.
SIR 2027 Annual Scientific Meeting (52nd)
March 20–24, 2027 · Los Angeles Convention Center, Los Angeles, CA, USA — Flagship Society of Interventional Radiology meeting covering breakthrough minimally invasive, image-guided treatments; registration opens October 2026.
https://www.sirweb.org/education/events/sir-2027-annual-scientific-meeting/
Also added to the Conferences calendar.
Other relevant information
IceCure Medical wins China NMPA approval for ProSense cryoablation system
On September 10, 2026, IceCure Medical announced it received Class III medical device approval from China's National Medical Products Administration (NMPA) for its ProSense minimally-invasive cryoablation system and associated cryoprobes, opening the Chinese market to the image-guided, freezing-based tumor-destruction platform.
University of Michigan opens $10M Histotripsy Center
A ribbon-cutting was held on September 10, 2026 for the University of Michigan Histotripsy Center, a first-of-its-kind, $10 million facility (funded by HistoSonics, Michigan Engineering, and private donors) that gives outside researchers free access to specialized equipment and inventor-level expertise to advance the noninvasive, ultrasound-guided tumor-ablation technique beyond its FDA-cleared liver indication into kidney, brain, and other applications.
microtherapy.world is published by Prof. Dr. Michael Friebe (friebelab.org). Scores and evaluations in this newsletter are an informational screening signal, not a regulatory endorsement, clinical recommendation, or substitute for procurement due diligence or independent clinical judgement — see the Methodology page for the full scoring rubric. Research summaries are drawn from publicly available sources (PubMed and web search) and are not independently verified beyond what the cited source itself states. This newsletter is not medical advice.